Reduction of Hepatopulmonary and Intrahepatic Shunts after Treatment with Sorafenib in Hepatocellular Carcinoma Patients.

Balli, Huseyin Tugsan; Aikimbaev, Kairgeldy; Burak, Isa Guney; Pehlivan, Umur Anil; Piskin, Ferhat Can; Sozutok, Sinan

Balli, Huseyin Tugsan; Aikimbaev, Kairgeldy; Burak, Isa Guney; Pehlivan, Umur Anil; Piskin, Ferhat Can; Sozutok, Sinan.

Afiliação

Balli HT; Department of Radiology, Balcali Hospital, Cukurova University Medical School, Adana, Turkey.
Aikimbaev K; Department of Radiology, Balcali Hospital, Cukurova University Medical School, Adana, Turkey. aikimbaev@gmail.com.
Burak IG; Department of Nuclear Medicine, Balcali Hospital, Cukurova University Medical School, Adana, Turkey.
Pehlivan UA; Medical Faculty Radiology Department, Balcali Hospital, Cukurova University, Adana, Turkey.
Piskin FC; Medical Faculty Radiology Department, Balcali Hospital, Cukurova University, Adana, Turkey.
Sozutok S; Medical Faculty Radiology Department, Balcali Hospital, Cukurova University, Adana, Turkey.

Cardiovasc Intervent Radiol ; 45(12): 1842-1847, 2022 Dec.

Article em En | MEDLINE | ID: mdl-36175653

Assuntos

Carcinoma Hepatocelular; Embolização Terapêutica; Neoplasias Hepáticas; Humanos; Carcinoma Hepatocelular/tratamento farmacológico; Carcinoma Hepatocelular/patologia; Sorafenibe/uso terapêutico; Radioisótopos de Ítrio/uso terapêutico; Neoplasias Hepáticas/terapia; Estudos Retrospectivos; Embolização Terapêutica/métodos; Resultado do Tratamento

Palavras-chave

Hepatocellular carcinoma; Hepatopulmonary shunt; Intrahepatic shunts; Sorafenib; Transarterial radioembolization; Yttrium-90

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Embolização Terapêutica / Neoplasias Hepáticas Tipo de estudo: Guideline / Observational_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google